Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands

16 references·14 citing·37 second hop

FromToDepth

this work references cited by second hop

References

1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
1990World Development Report 1990.1,744 cited
2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
1994Epidemiology of blood transfusion149 cited
2001Estimated risk of HIV transmission by blood transfusion in Kenya129 cited
2001Screening for viral markers in volunteer and replacement blood donors in West Africa121 cited
2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
2007Transfusion in sub-Saharan Africa: does a Western model fit?71 cited
2001Residual risk of transfusion in Ghana51 cited
2009One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations48 cited
2003Human immunodeficiency virus‐1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing47 cited
2001

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Long‐term survival in transfusion recipients in Sweden, 1993

43 cited

2005Does prevalence of transfusion‐transmissible viral infection reflect corresponding incidence in United States blood donors?38 cited

2004Economic analyses of blood safety and transfusion medicine interventions: a systematic review35 cited

Cited by

2009Health economics of blood transfusion safety – focus on sub-Saharan Africa28 cited
2017Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty28 cited
2016Residual risk and waste in donated blood with pooled nucleic acid testing24 cited
2013Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first‐time and repeat blood donations in Z imbabwe: implications on blood safety19 cited
2014Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India19 cited
2014Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus17 cited
2011Optimal selection of screening assays for infectious agents in donated blood17 cited
2017An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries16 cited
2011Safety and waste considerations in donated blood screening15 cited
2020HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods15 cited
2016Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe14 cited
2017Development of a web‐based application and multicountry analysis framework for assessing interdicted infections and cost‐utility of screening donated blood for HIV , HCV and HBV14 cited
2014A probabilistic method for the estimation of residual risk in donated blood11 cited
2016Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Z imbabwe8 cited